Skip to main content
Top
Published in: BMC Infectious Diseases 1/2023

Open Access 01-12-2023 | Correction

Correction: Can HIV self-testing reach first-time testers? A telephone survey among self-test end users in Côte d’Ivoire, Mali, and Senegal

Authors: Arsène Kouassi Kra, Arlette Simo Fotso, Kouassi Noël N’guessan, Olivier Geoffroy, Sidibé Younoussa, Odé Kanku Kabemba, Papa Alioune Gueye, Pauline Dama Ndeye, Nicolas Rouveau, Marie-Claude Boily, Romain Silhol, Marc d’Elbée, Mathieu Maheu-Giroux, Anthony Vautier, Joseph Larmarange, on behalf of the ATLAS team

Published in: BMC Infectious Diseases | Issue 1/2023

Login to get access

Excerpt

BMC Infectious Diseases (2023) 22:972
Metadata
Title
Correction: Can HIV self-testing reach first-time testers? A telephone survey among self-test end users in Côte d’Ivoire, Mali, and Senegal
Authors
Arsène Kouassi Kra
Arlette Simo Fotso
Kouassi Noël N’guessan
Olivier Geoffroy
Sidibé Younoussa
Odé Kanku Kabemba
Papa Alioune Gueye
Pauline Dama Ndeye
Nicolas Rouveau
Marie-Claude Boily
Romain Silhol
Marc d’Elbée
Mathieu Maheu-Giroux
Anthony Vautier
Joseph Larmarange
on behalf of the ATLAS team
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2023
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-023-08668-0

Other articles of this Issue 1/2023

BMC Infectious Diseases 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine